TH165979B - Reducing the inflammatory response - Google Patents
Reducing the inflammatory responseInfo
- Publication number
- TH165979B TH165979B TH1501005309A TH1501005309A TH165979B TH 165979 B TH165979 B TH 165979B TH 1501005309 A TH1501005309 A TH 1501005309A TH 1501005309 A TH1501005309 A TH 1501005309A TH 165979 B TH165979 B TH 165979B
- Authority
- TH
- Thailand
- Prior art keywords
- reducing
- inflammatory response
- hydrolyzate
- elements
- molecular weight
- Prior art date
Links
- 230000028709 inflammatory response Effects 0.000 title abstract 2
- 206010061218 Inflammation Diseases 0.000 claims abstract 3
- 230000004054 inflammatory process Effects 0.000 claims abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract 3
- 239000005018 casein Substances 0.000 claims abstract 2
- 235000021240 caseins Nutrition 0.000 claims abstract 2
- 200000000018 inflammatory disease Diseases 0.000 claims abstract 2
- 239000000470 constituent Substances 0.000 claims 2
- 230000001737 promoting Effects 0.000 claims 2
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
- 244000145841 kine Species 0.000 abstract 1
Abstract
คำขอใหม่ปรับปรุงวันที่ 7/03/2559 การเปิดเผยนี้ให้วิธีเพื่อกดการตอบสนองแบบส่งเสริมการอักเสบโดยการให้องค์ประกอบซึ่ง ประกอบรวมด้วยเปปไทด์ที่เลือกจากเคซีนไฮโดรไลเซต องค์ประกอบดังกล่าวอาจลดระดับของไซโต ไคน์ส่งเสริมการอักเสบและอาจเป็นการรักษาสำหรับโรคอักเสบโดยเฉพาะอย่างยิ่งโรคเบาหวานชนิดที่ 1 ที่ควรใช้คือไฮโดรไลเซตประกอบด้วยเปปไทด์ที่มีน้ำหนักโมเลกุลมากกว่า 500 Da New Request. Updated 07/03/2016 This disclosure provides a way to suppress the inflammatory response by providing elements that Contains peptides selected from casein hydrolyzate Such elements may reduce levels of cytos. The kine promotes inflammation and may be a treatment for inflammatory diseases, especially type 1 diabetes, preferably a hydrolyzate containing peptides with a molecular weight of more than 500 Da.
Claims (1)
Publications (3)
Publication Number | Publication Date |
---|---|
TH1501005309A TH1501005309A (en) | 2017-08-10 |
TH165979A TH165979A (en) | 2017-08-10 |
TH165979B true TH165979B (en) | 2017-08-10 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123229T1 (en) | USE OF CANNABINOIDS IN THE TREATMENT OF ATONIC SEIZURES IN LENNOX-GASTAUT SYNDROME | |
PH12015502102B1 (en) | Reducing proinflammatory response | |
CL2017000864A1 (en) | Compositions and methods of use to treat metabolic disorders | |
CL2018002814A1 (en) | Compositions and methods for the treatment of wounds, disorders, and skin diseases. | |
PE20180243A1 (en) | COMPOSITIONS INCLUDING BACTERIAL STRAINS | |
BR112018009706A8 (en) | compositions comprising bacterial strains | |
BR112018009213A2 (en) | compositions comprising bacterial strains | |
EA201891199A1 (en) | COMPOSITIONS CONTAINING BACTERIAL STRAINS | |
EA201890047A1 (en) | COMPOSITIONS CONTAINING BACTERIAL STRAINS | |
EA201890747A1 (en) | METHODS OF TREATING INFLAMMATORY DISEASES | |
MX2016013243A (en) | Peptidic dual glp-1 / glucagon receptor agonists derived from exendin-4. | |
PE20190117A1 (en) | COMPOUNDS OF MIC-1 AND USES OF THEM | |
CO2018001840A2 (en) | Biopharmaceutical compositions comprising anti-il-5 antibodies | |
MX2017015922A (en) | Biomarkers associated with lsd1 inhibitors and uses thereof. | |
WO2015026249A8 (en) | Use of a mir172 molecule for decreasing inflammation | |
CL2016001786A1 (en) | Regulation of ornithine metabolism to manipulate the mannose-rich glycoform content of recombinant proteins. | |
IL283929A (en) | Treatment of 22q11.2 deletion syndrome with cannabidiol | |
EA201791937A1 (en) | ANTI-INFLAMMATORY POLYPEPTIDES | |
PH12015502100A1 (en) | Reducing the risk of autoimmune disease | |
WO2018071504A3 (en) | Methods of treating diseases with il-23a antibody | |
BR112017014552A2 (en) | ? calcitonin analog, and method for producing a decrease in triglycerides in the liver / reduction of fat accumulation in the liver? | |
TH165979B (en) | Reducing the inflammatory response | |
EA202090728A1 (en) | APPLICATION OF NOR-URSODEOXYCHOLIC ACID TO REDUCE LIVER FAT | |
TH165979A (en) | Reducing the inflammatory response | |
WO2017042577A8 (en) | Novel therapy |